Study of BioTTT001 for advanced solid tumors
Treatments studied
Part of Infections clinical trials.
This trial tests a new drug, BioTTT001, given as a shot directly into tumors. It is for people with certain advanced solid tumors that have stopped responding to standard treatments or who have no other options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 18 and 80 years old.
- Diagnosed with advanced solid tumors like head and neck, colorectal, skin, or cervical cancer.
- At least one tumor that can be measured on scans.
- A tumor that can be safely injected with the study drug.
- Standard treatments have stopped working, caused bad side effects, or are not available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
This Phase 1 study tests BAT8008 injection to see how safe it is, how well the body handles it, and how it affects the body’s drug levels. It’s for adults with advanced or metastatic solid tumors that are not responding to, or can’t be tolerated with, standard treatments.
This trial tests a new drug called BioTTT001 combined with toripalimab and regorafenib for people with colorectal cancer that has spread to the liver. It is for those who have tried at least two prior treatments or cannot have standard therapies.
This study tests a new treatment using your body's own immune cells (called tumor-infiltrating lymphocytes) that are taken from your tumor, grown in a lab, and then put back into you. It's for people with advanced solid tumors who have run out of standard options.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.